Lataa...
Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis B
The aim of this review is to outline emerging biomarkers that can serve as diagnostic tools to identify non-cirrhotic chronic hepatitis B (CHB) patients who could safely discontinue nucleos(t)ide analogues (NAs) before HBsAg loss. Regarding possible predictors of post-NAs outcomes, a number of studi...
Tallennettuna:
| Julkaisussa: | Cells |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7072769/ https://ncbi.nlm.nih.gov/pubmed/32093411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020493 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|